Search results for "Gestational"

showing 10 items of 352 documents

Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis.

1986

Neurons from rat fetal cerebral hemispheres were grown in a synthetic medium (Maat medium), as previously described, for different periods of time. The repeat length of their chromatin was determined by micrococcal nuclease digestion and compared with that of neurons isolated from postnatal rat brain of corresponding ages. In contrast to the in vivo situation, we found that neurons, dissociated at the 16th gestational day and cultured in vitro, did not undergo the shortening of their chromatin repeat, thus indicating that, at the end of their mitotic cycles, they are not yet programmed to this event. © 1986.

Settore MED/07 - Microbiologia E Microbiologia ClinicaAgingCellular differentiationCentral nervous systemGestational AgeFetusPregnancymedicineAnimalsMitosisCells CulturedCell NucleusNeuronsFetusbiologyNeurogenesisBrainCell DifferentiationdifferentiationCell BiologyDNAneuronChromatinChromatinCell biologyRatsMolecular Weightmedicine.anatomical_structureSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaImmunologybiology.proteinSettore MED/26 - NeurologiaFemaleNeuronMicrococcal nucleaseCell biology international reports
researchProduct

Prenatal sonographic chest and lung measurements for predicting severe pulmonary hypoplasia.

1999

Pulmonary hypoplasia was diagnosed sonographically in 32 fetuses from 20 to 33 weeks of gestation. In addition to standard biometry, transverse thoracic diameter (TTD), sagittal thoracic diameter (TSD), thoracic circumference (TC) and lung diameter (LD) were measured in all cases and compared with known nomograms. The fetuses were divided into five groups according to the main sonographic findings: group 1—skeletal dysplasia; group 2—renal agenesis; group 3—diaphragmatic hernia; group 4—hydrothorax; and group 5—others. Severe pulmonary hypoplasia (PH) was diagnosed prenatally in all cases on the basis of LD measurements. In 17 (53.1 per cent) out of 32 cases TTD was below the 5th percentile…

ThoraxLung Diseasesmedicine.medical_specialtyHydrothoraxGestational AgeKidneyUltrasonography PrenatalPulmonary hypoplasiaPregnancyMedicineHumansDiaphragmatic herniaProspective StudiesRenal agenesisLungGenetics (clinical)Hernia DiaphragmaticBone Diseases DevelopmentalLungbusiness.industryRespiratory diseaseObstetrics and GynecologyThoraxmedicine.diseaseHypoplasiaSurgeryFetal Diseasesmedicine.anatomical_structureAgenesisFemaleRadiologybusinessPrenatal diagnosis
researchProduct

Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth A Systematic Review and Meta-analysis

2019

Preterm birth complicates 5% to 15% of births worldwide, and although it is the most important direct cause of morbidity and mortality in children younger than 5 years, no known risk factors can be identified in the majority of cases. However, overt hypothyroidism and hyperthyroidism during pregnancy are well-known risk factors for preterm birth, and as such, the purpose of this study was to assess whether thyroid function test abnormalities and thyroid peroxidase (TPO) antibody positivity were associated with preterm birth. The study conducted a systematic review on the association of thyroid function or autoimmunity with preterm birth published from database inception to March 18, 2018, w…

Thyrotropin/bloodIodide Peroxidase/immunologyPremature Birth/etiologyThyrotropinHypothyroidism/complicationsThyroid Function Tests01 natural sciencesThyroxine/blood0302 clinical medicineMaternal hypothyroidismThyroid Diseases/bloodPregnancyEuthyroid030212 general & internal medicine030219 obstetrics & reproductive medicinebiologymedicine.diagnostic_testObstetricsThyroid diseaseAbsolute risk reductionObstetrics and GynecologyGestational ageGeneral MedicinePremature birthPremature BirthFemaleThyroid functionmedicine.drugAdultendocrine systemmedicine.medical_specialtyLevothyroxineGestational AgeIodide PeroxidaseThyroid function testsAutoimmune Diseases03 medical and health sciencesHypothyroidismThyroid peroxidasemedicineVery Preterm BirthHumans0101 mathematicsAutoantibodiesPregnancybusiness.industry010102 general mathematicsInfant NewbornInfantOdds ratioNewbornmedicine.diseaseThyroid DiseasesPregnancy Complications/bloodPregnancy ComplicationsThyroxineAutoimmune Diseases/bloodbiology.proteinAutoantibodies/bloodbusiness
researchProduct

Early cardiovascular events in women with a history of gestational diabetes mellitus

2016

International audience; Background: The effect of gestational diabetes mellitus (GDM) on cardiovascular diseases (CVD) is not assessed within the first 10 years postpartum, regardless of subsequent diabetes. The aim of this study was to determine the risk of CVD events related to GDM within 7 years of postpartum.Methods: This nationwide population-based study of deliveries in 2007 and 2008 with a follow-up of 7 years was based on data from the French medico-administrative database. Two groups were formed: women with a history of GDM and women without GDM or previous diabetes. CVD included angina pectoris, myocardial infarction, stroke, heart bypass surgery, coronary angioplasty, carotid end…

Time FactorsDatabases Factualendocrine system diseasesEndocrinology Diabetes and MetabolismComorbidity030204 cardiovascular system & hematologyVascular dysfunctionAnginaDiabetes mellitus0302 clinical medicineRisk FactorsPregnancyOdds RatioPrevalenceGestational diabetesOriginal InvestigationCoronary diseaseeducation.field_of_study[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMetaanalysis[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismCardiovascular disease3. Good healthGestational diabetesCardiovascular DiseasesHypertensionFemaleFranceCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyPopulationAdministrative data030209 endocrinology & metabolismRisk AssessmentYoung Adult03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineDiabetes mellitusmedicineHumansHeart bypasscardiovascular diseasesRisk factoreducationbusiness.industryOdds ratiomedicine.diseaseComorbidityDiabetes GestationalLogistic ModelsCase-Control StudiesbusinessCardiovascular Diabetology
researchProduct

Associations of Maternal Cell-Phone Use During Pregnancy With Pregnancy Duration and Fetal Growth in 4 Birth Cohorts

2019

Results from studies evaluating potential effects of prenatal exposure to radio-frequency electromagnetic fields from cell phones on birth outcomes have been inconsistent. Using data on 55,507 pregnant women and their children from Denmark (1996-2002), the Netherlands (2003-2004), Spain (2003-2008), and South Korea (2006-2011), we explored whether maternal cell-phone use was associated with pregnancy duration and fetal growth. On the basis of self-reported number of cell-phone calls per day, exposure was grouped as none, low (referent), intermediate, or high. We examined pregnancy duration (gestational age at birth, preterm/postterm birth), fetal growth (birth weight ratio, small/large size…

Time FactorsEpidemiologyDenmarkOriginal ContributionsFetal Developmentstress0302 clinical medicinePregnancyRisk FactorsFetal growthBirth outcomes030212 general & internal medicineNetherlandsObstetricsConfoundingHazard ratio1. No povertyPregnancy OutcomeGestational age3. Good healthbehavioral-problems1st trimesterPremature birth030220 oncology & carcinogenesisPremature BirthFemaleAdultmedicine.medical_specialtyradio-frequency electromagnetic fieldsBirth weightCell phonescell phonesGestational AgeExposure03 medical and health sciencesRepublic of KoreamedicineHumansradio-frequency electronRadio-frequency electromagnetic fieldsPregnancybusiness.industryabsorption ratesbirth outcomespreterm birthweightPreterm birthmedicine.diseaseConfidence intervalwhole-bodyradiationSpainexposurebusinessCell PhoneAmerican Journal of Epidemiology
researchProduct

Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe : impact of maternal age and prenatal screening

2013

This study examines trends and geographical differences in total and live birth prevalence of trisomies 21, 18 and 13 with regard to increasing maternal age and prenatal diagnosis in Europe. Twenty-one population-based EUROCAT registries covering 6.1 million births between 1990 and 2009 participated. Trisomy cases included live births, fetal deaths from 20 weeks gestational age and terminations of pregnancy for fetal anomaly. We present correction to 20 weeks gestational age (ie, correcting early terminations for the probability of fetal survival to 20 weeks) to allow for artefactual screening-related differences in total prevalence. Poisson regression was used. The proportion of births in …

TrisomyAbortionPregnancyPrenatal DiagnosisDown Syndrome/diagnosisMedicinetrisomy 18Registriestrisomy 13Genetics (clinical)Geneticseducation.field_of_studyObstetricsPregnancy OutcomeDown syndrome -- Case studiesGestational ageEuropetrisomy 21Fetal Death/epidemiologyFemaleLive birthLive BirthMaternal AgetrendsAdultmedicine.medical_specialtyDown syndromeMedical screeningPopulationPrenatal diagnosisArticlePregnancy Outcome/epidemiologyEurope/epidemiologyAge DistributionGeneticsHumanseducationFetal DeathMaternal agePregnancyChromosomes Human Pair 13business.industryAbortion Inducedmedicine.diseaseTrisomy/diagnosisLive Birth/epidemiologyprenatal screeningTrisomy -- Patients -- CareDown SyndromebusinessTrisomyChromosomes Human Pair 18Abortion Induced/statistics & numerical data
researchProduct

Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia.

2007

Fetuses from mothers with gestational diabetes are at increased risk of developing neonatal macrosomia and oxidative stress. We investigated the modulation of antioxidant status and circulating lipids in gestational diabetic mothers and their macrosomic babies and in healthy age-matched pregnant women and their newborns. The serum antioxidant status was assessed by employing anti-radical resistance kit (KRL; Kirial International SA, Couternon, France) and determining levels of vitamin A, C, and E and the activity of superoxide dismutase (SOD). Circulating serum lipids were quantified, and lipid peroxidation was measured as the concentrations of serum thiobarbituric acid-reactive substances …

VitaminAdultmedicine.medical_specialtymedicine.medical_treatmentBlood lipidsAscorbic AcidThiobarbituric Acid Reactive SubstancesAntioxidantsFetal MacrosomiaLipid peroxidationchemistry.chemical_compoundPregnancyPhysiology (medical)Internal medicineTBARSFetal macrosomiaMedicineHumansVitamin EVitamin ATriglyceridesbusiness.industrySuperoxide DismutaseVitamin EBiochemistry (medical)Public Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseAscorbic acidLipidsGestational diabetesDiabetes GestationalEndocrinologyCholesterolchemistryFemalebusinessTranslational research : the journal of laboratory and clinical medicine
researchProduct

Dietary exposure in utero and during lactation to a mixture of genistein and an anti-androgen fungicide in a rat mammary carcinogenesis model

2015

Endocrine disruptors may play substantial roles in the high incidence of breast cancer. We previously described how early exposure to the mixture of phytoestrogen genistein (G) and the anti-androgen vinclozolin (V) affects peripubertal mammary development. This study evaluates the carcinogenic potential of exposure to V alone or associated with G from conception until weaning in Wistar rats. Dams were exposed to V, G or GV during pregnancy/lactation. At PND50 offspring were treated with DMBA[7,12-dimethylbenz(a)anthracene]. V or GV maternal exposure decreased number of DMBA-induced mammary tumors in the offspring, without significant modifications in tumor incidence, multiplicity and latenc…

[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionGenisteinDMBAEndocrine DisruptorsToxicologymedicine.disease_causechemistry.chemical_compound0302 clinical medicinePregnancyRisk FactorsLactationVinclozolinOxazoles0303 health sciencesAge Factorsendocrine disruptionGenisteinTumor Burden3. Good health[ SDV.BDLR ] Life Sciences [q-bio]/Reproductive Biologymedicine.anatomical_structuregestational and lactational exposureReceptors EstrogenMaternal ExposureIn utero030220 oncology & carcinogenesisphytoestrogenFemaleReceptors ProgesteroneCarcinoma in Situmedicine.medical_specialtyendocrine systemanti-androgenOffspring910-Dimethyl-12-benzanthraceneBreast NeoplasmsGestational AgeBiologyRisk Assessment03 medical and health sciencesMammary Glands AnimalPrenatal Educationmammary gland carcinogenesisInternal medicinemedicineAnimalsEndocrine systemRats WistarCell Proliferation030304 developmental biologyAndrogen AntagonistsEpithelial Cells[SDV.BDLR]Life Sciences [q-bio]/Reproductive BiologyDietFungicides IndustrialDisease Models AnimalEndocrinologychemistryCarcinogenesis[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food co…

2011

The impact of early exposure to endocrine disruptor mixtures on mammary gland development is poorly known. Here, we identify the effects of a conception to weaning exposure of rats to the phytoestrogen genistein (G) and/or the antiandrogen vinclozolin (V) at 1 mg/kg-d, alone or in association. Using several approaches, we found that G- and GV-exposed rats displayed significantly greater epithelial branching and proliferation, wider terminal end buds than controls at PND35, as well as ductal hyperplasia and periductal fibrosis. Focal branching defects were present in V-exposed rats. An increased ER and AR expression was observed in G- and CV- as compared to V-exposed rats at PND35. Surprisin…

[SDV.BA] Life Sciences [q-bio]/Animal biology[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionreceptorGenisteinmammary gland developmentsprague-dawley ratsToxicologyAntiandrogen[ SDV.BA ] Life Sciences [q-bio]/Animal biologychemistry.chemical_compound0302 clinical medicineLactationSexual MaturationVinclozolinReceptorOxazolesfemale mice0303 health sciences[SDV.BA]Life Sciences [q-bio]/Animal biologyendocrine disruptiondifferentiationGenisteinDrug Combinationsmedicine.anatomical_structuregestational and lactational exposureEndocrine disruptorMaternal ExposureIn utero030220 oncology & carcinogenesisVaginaphytoestrogenFemalemedicine.medical_specialtyanti-androgenbreast-cancer riskmedicine.drug_classgrowthFood ContaminationPhytoestrogensandrogenBiologytransgenic mice03 medical and health sciencesMammary Glands AnimalInternal medicinemedicineAnimalsLactationRats Wistar030304 developmental biologyHyperplasiaBody WeightAndrogen AntagonistsAndrogenRats[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionbisphenol-a alterstumorigenesisEndocrinologychemistrycells[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Use of hospital and amubutory data in assessment of screnning, follow-up and complications of diabetes mellitus

2017

Diabetes is a priority health target worldwide. Access to conclusive data is equally a priority in order to establish clear objectives and to implement coordinated action. Medico-administrative databases are being used more and more frequently for this purpose. We set out to illustrate and assess the interest of using a French healthcare consumption database to evaluate screening, surveillance and the risk of acute or chronic complications of diabetes in certain at-risk populations. We concluded that early screening for type-2 diabetes in women with a history of gestational diabetes was inadequate. Although a slight improvement occurred following the recommendations published in 2010, one w…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyPmsiDiabète gestationnelGestational diabetes mellitusDonnées médico-AdministrativesDiabète type 2Cardio-Vascular diseasesMaladies cardio-VasculairesType 2 diabetes mellitusHospital dataSchizophreniaSchizophrénie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAmbulatory data
researchProduct